Clinical Trial Update: YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of the YMN-136 vaccine for liver metastases from colorectal cancer, in patients who progressed after third-line treatment, is not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• YMN-136 vaccine (YMN-136)

Snippet

Sponsor: West China Hospital | Conditions: Colorectal Cancer | Phase 1 | Status: NOT_YET_RECRUITING